ישראל - עברית - Ministry of Health

syneron medical - אחר - the co2re system is indicated for use in the performance of dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - the discovery nm/ct 570c system intended uses include performing nuclear cardiac imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes as well as performing general head & body computed tomography (ct) applications

ישראל - עברית - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - system is to perform nuclear imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes. discovery nm 530c is primarily intended for cardiac applications.

ישראל - עברית - Ministry of Health

voyant health ltd. - רופא - the traumacad program is indicated for assisting healthcare professionals in preoperative planning of orthopedic surgery. the device allows for overlaying of prosthesis templates on radiological images, and includes tools for performing measurements on the image and for positioning the template.

ישראל - עברית - Ministry of Health

meditrend marketing (2004) ltd, israel - benzoxonium chloride; chlorhexidine gluconate - תמיסה - benzoxonium chloride 1 mg/ml; chlorhexidine gluconate 5 mg/ml - chlorhexidine, combinations - chlorhexidine, combinations - to disinfect wounds and injuries, such as cuts, scratches, mild burns and insect stings.

ישראל - עברית - Ministry of Health

לילית קוסמטיקה בעמ - לחות לפנים

ישראל - עברית - Ministry of Health

אנה לוטן בעמ - עיסוי העור

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - trastuzumab - תמיסה לאינפוזיה - trastuzumab 440 mg/ml - trastuzumab - trastuzumab - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: 1. as a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease. 2. in combination with paclitaxel or docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. 3. herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer. early breast cancer (ebc) :herceptin is indicated to treat patients with her2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines. herceptin should only be used in patients whose tumors have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.her2 metastatic gastric cancer (mgc)herceptin in

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - varicella virus, live attenuated - אבקה וממס להכנת תמיסה להזרקה - varicella virus, live attenuated nlt 10^3.3 pfu - varicella zoster vaccines - in the event of negative anamnesis, for the active immunisation against varicella in healthy subjects only from the age of 12 months.